Salomon Stemmer
Tracked across 1 events · 6 articles · First seen Jul 01, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Prof. Salomon Stemmer, the lead investigator of the Phase 2a study, provided expert commentary supporting the promising results of Namodenoson and recommended its further evaluation in combination with chemotherapy.
Jul 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Salomon Stemmer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard